{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T09:23:54Z","timestamp":1774430634876,"version":"3.50.1"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Acute lymphoblastic leukemia (ALL) is the most common malignancy in childhood, but it is relatively rare in infants. However, infant ALL exhibits distinct biological characteristics and an aggressive course, with a high proportion of cases involving MLL gene rearrangements (particularly the MLL-AF4 fusion gene). Leukemia driven by MLL-AF4 is extremely rare across all populations but represents a critical and poor-prognosis subtype within infant ALL.ALL driven by the MLL-AF4 fusion is exceptionally rare and particularly fulminant. We report monochorionic monozygotic twins who presented simultaneously with MLL-AF4 positive ALL. Both neonates exhibited fever, pallor, hepatosplenomegaly and extreme leucocytosis. After achieving complete remission with the St.Jude Total Therapy XV (TOTXV) protocol, the twins experienced molecular relapse and were successfully rescued with sequential CD19- and CD22-directed CAR-T-cell therapy. Owing to parental preference and financial constraints, neither patient proceeded to allogeneic haematopoietic stem-cell transplantation; instead, they received consolidative chemotherapy. At 8 years of age, both children remain in sustained molecular remission and enjoy age-appropriate development. This concordant twin pair illustrates the natural history of MLL-AF4-positive infant ALL, supports the curative potential of CAR-T-cell therapy in this ultra-high-risk population, and emphasises the importance of prolonged molecular surveillance.<\/jats:p>","DOI":"10.3389\/fped.2026.1777726","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T06:52:28Z","timestamp":1774421548000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Concurrent MLL-AF4+ infant ALL in monozygotic twins: a case report"],"prefix":"10.3389","volume":"14","author":[{"given":"Chenghui","family":"Li","sequence":"first","affiliation":[{"name":"Dalian Women and Children\u2019s Medical Group, Hematology-Oncology Department","place":["Dalian, Liaoning, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Tong","sequence":"additional","affiliation":[{"name":"Dalian Women and Children\u2019s Medical Group, Department of Pharmacy","place":["Dalian, Liaoning, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinfeng","family":"Yang","sequence":"additional","affiliation":[{"name":"Dalian Women and Children\u2019s Medical Group, Hematology-Oncology Department","place":["Dalian, Liaoning, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Gao","sequence":"additional","affiliation":[{"name":"Dalian Women and Children\u2019s Medical Group, Hematology-Oncology Department","place":["Dalian, Liaoning, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhong","family":"Li","sequence":"additional","affiliation":[{"name":"Dalian Women and Children\u2019s Medical Group, Department of Pharmacy","place":["Dalian, Liaoning, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3000605231167789","DOI":"10.1177\/03000605231167789","article-title":"Infantile B-lymphoblastic leukemia: a case series and review of the literature","volume":"51","author":"Mansoor","year":"2023","journal-title":"J Int Med Res"},{"key":"B2","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/s41408-023-00924-5","article-title":"Late effects in survivors of infant acute lymphoblastic leukaemia-a study of the Australian and New Zealand children\u2019s haematology\/oncology group","volume":"13","author":"Mironova","year":"2023","journal-title":"Blood Cancer J"},{"key":"B3","doi-asserted-by":"publisher","first-page":"865979","DOI":"10.1155\/2014\/865979","article-title":"Characterization of pediatric acute lymphoblastic leukemia survival patterns by age at diagnosis","volume":"2014","author":"Hossain","year":"2014","journal-title":"J Cancer Epidemiol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"103185","DOI":"10.1016\/j.scr.2023.103185","article-title":"Generation of a human induced pluripotent stem cell line harboring the infant leukemia-associated fusion gene, KMT2A-AFF1 (IMSUTi002-A-2)","volume":"71","author":"Takahashi","year":"2023","journal-title":"Stem Cell Res"},{"key":"B5","doi-asserted-by":"publisher","first-page":"639479","DOI":"10.3389\/fped.2021.639479","article-title":"The prenatal origin of childhood leukemia: potential applications for epidemiology and newborn screening","volume":"9","author":"Marcotte","year":"2021","journal-title":"Front Pediatr"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e299","DOI":"10.1097\/MPH.0000000000000098","article-title":"Two pairs of monozygotic twins with concordant acute lymphoblastic leukemia (ALL): case report","volume":"36","author":"Li","year":"2014","journal-title":"J Pediatr Hematol Oncol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1182\/blood-2005-07-3011","article-title":"Analysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953 from the children\u2019s oncology group","volume":"108","author":"Hilden","year":"2006","journal-title":"Blood"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1182\/bloodadvances.2024014869","article-title":"Supernumerary ring chromosome 1 syndrome leads to fusion-driven B-cell acute lymphoblastic leukemia in monozygotic twins","volume":"9","author":"Guti\u00e9rrez-Abril","year":"2025","journal-title":"Blood Advances"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2676","DOI":"10.1182\/blood-2015-09-667378","article-title":"Revisiting the biology of infant t(4;11)\/MLL-AF4+ B-cell acute lymphoblastic leukemia","volume":"126","author":"Sanjuan-Pla","year":"2015","journal-title":"Blood"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1002\/pbc.25957","article-title":"Unique familial MLL(KMT2A)-rearranged precursor B-cell infant acute lymphoblastic leukemia in non-twin siblings","volume":"63","author":"Urtishak","year":"2016","journal-title":"Pediatr Blood Cancer"},{"key":"B11","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0022-3476(62)80014-6","article-title":"Parallel responses to chemotherapy in identical twin infants with concordant leukemia","volume":"60","author":"Wolman","year":"1962","journal-title":"J Pediatr"},{"key":"B12","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/S0140-6736(71)92705-X","article-title":"Possible explanation of the high concoddance for acute leukaemia in monozygotic twins","volume":"1","author":"Clarkson","year":"1971","journal-title":"Lancet (London, England)"},{"key":"B13","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s13148-025-01906-z","article-title":"DNA methylation in monozygotic twins discordant for acute lymphoblastic leukemia: a case report and systematic review","volume":"17","author":"Sun","year":"2025","journal-title":"Clin Epigenetics"},{"key":"B14","doi-asserted-by":"publisher","first-page":"3553","DOI":"10.1182\/blood-2009-10-251413","article-title":"Acquisition of genome-wide copy number alterations in monozygotic twins with acute lymphoblastic leukemia","volume":"115","author":"Bateman","year":"2010","journal-title":"Blood"},{"key":"B15","doi-asserted-by":"publisher","first-page":"9740","DOI":"10.3390\/ijms22189740","article-title":"Genetic and epigenetic characterization of a discordant KMT2A\/AFF1-rearranged infant monozygotic twin pair","volume":"22","author":"Russo","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B16","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/leu.2009.262","article-title":"Long-term results of the children\u2019s cancer group studies for childhood acute lymphoblastic leukemia 1983\u20132002: a children\u2019s oncology group report","volume":"24","author":"Gaynon","year":"2010","journal-title":"Leukemia"},{"key":"B17","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s12032-025-03124-2","article-title":"Menin inhibitors as targeted therapy in KMT2A-rearranged acute leukemia: a comprehensive review of current advances and therapeutic implications","volume":"43","author":"Ahmed","year":"2025","journal-title":"Med Oncol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1608768","DOI":"10.3389\/fimmu.2025.1608768","article-title":"Efficacy and safety of chimeric antigen receptor T-cell in the treatment of hematologic malignancy: an umbrella review of systematic review and meta-analysis","volume":"16","author":"Yu","year":"2025","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"31459","DOI":"10.34172\/bi.31459","article-title":"CAR-T cell therapy as an approach for pediatric hematological malignancies in regenerative therapy: current status and clinical outcomes","volume":"15","author":"Guo","year":"2025","journal-title":"BioImpacts"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1056\/NEJMoa1215134","article-title":"Chimeric antigen receptor-modified T cells for acute lymphoid leukemia","volume":"368","author":"Grupp","year":"2013","journal-title":"N Engl J Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jcyt.2019.12.004","article-title":"The long road to the first FDA-approved gene therapy: chimeric antigen receptor T cells targeting CD19","volume":"22","author":"Braendstrup","year":"2020","journal-title":"Cytotherapy"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.1038\/s41375-019-0488-7","article-title":"CD22 CAR T-cell therapy in refractory or relapsed B acute lymphoblastic leukemia","volume":"33","author":"Pan","year":"2019","journal-title":"Leukemia"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1200\/JCO.22.01214","article-title":"Coadministration of CD19- and CD22-directed chimeric antigen receptor T-cell therapy in childhood B-cell acute lymphoblastic leukemia: a single-arm, multicenter, phase II trial","volume":"41","author":"Wang","year":"2023","journal-title":"J Clin Oncol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"11362","DOI":"10.3390\/ijms262311362","article-title":"Novel therapeutic approaches in pediatric acute lymphoblastic leukemia","volume":"26","author":"Marrapodi","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e70247","DOI":"10.1002\/hem3.70247","article-title":"Harmonization on defining B-cell recovery post CD19-CAR T-cell therapy in B-cell acute lymphoblastic leukemia: an international consensus statement","volume":"9","author":"Lamble","year":"2025","journal-title":"HemaSphere"},{"key":"B26","doi-asserted-by":"publisher","first-page":"blood-2025030951","DOI":"10.1182\/blood.2025030951","article-title":"Outcome of children with B-cell acute lymphoblastic leukemia with hypodiploidy or BCR::ABL1 fusion undergoing allogeneic HSCT","author":"Buechner","year":"2025","journal-title":"Blood"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1777726\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T06:52:29Z","timestamp":1774421549000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1777726\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,25]]},"references-count":26,"alternative-id":["10.3389\/fped.2026.1777726"],"URL":"https:\/\/doi.org\/10.3389\/fped.2026.1777726","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,25]]},"article-number":"1777726"}}